ASTEC.NS

Astec LifeSciences Limited [ASTEC.NS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ASTEC.NS Stock Summary

Top 10 Correlated ETFs

ASTEC.NS


Top 10 Correlated Stocks

ASTEC.NS


In the News

ASTEC.NS Financial details

Company Rating
Neutral
Market Cap
25.28B
Income
-509.39M
Revenue
4.31B
Book val./share
-
Cash/share
-
Dividend
1.5
Dividend %
0.14%
Employees
551
Optionable
No
Shortable
Yes
Earnings
04 Apr 2024
P/E
-78.72
Forward P/E
-
PEG
5.03
P/S
4.08
P/B
5.13
P/C
-
P/FCF
6135.36
Quick Ratio
0.29
Current Ratio
0.93
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-25.98
EPS next Y
-
EPS next Q
-
EPS this Y
-71.57%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-6.53%
Revenue last 5Y
7.83%
Revenue Q/Q
-54.15%
EPS Q/Q
81.17%
-
-
-
-
SMA20
19.02%
SMA50
32%
SMA100
-0.55%
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-13%
ROC
-0.02%
Gross Margin
33%
Oper. Margin
-2%
Profit Margin
-5%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
825.05-1541.65
52W High
-19.38%
52W Low
+50.59%
RSI
65
Rel Volume
0.62
Avg Volume
73.51K
Volume
45.9K
Perf Week
-1.78%
Perf Month
37.68%
Perf Quarter
5.07%
Perf Half Y
-6.03%
-
-
-
-
Beta
0.34
-
-
Volatility
20.79%, 102.41%
Prev Close
-1.52%
Price
1242.35
Change
-0.69%

ASTEC.NS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric History 2019-03-312020-03-312021-03-312022-03-31 2023-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
220.45267.15283.45345.36320.44
Net income per share
18.2824.2933.2345.8713.04
Operating cash flow per share
7.8286.1-4.1712.0538.08
Free cash flow per share
-19.1862.95-56.54-41.03-21.73
Cash per share
0.231.190.791.711.4
Book value per share
103.59126.04157.94202.4213.93
Tangible book value per share
102.52124.39155.37196.67205.91
Share holders equity per share
103.59126.04157.94202.4213.93
Interest debt per share
96.256.998.05147.23184.61
Market cap
10.49B7.6B19.65B34.39B27.15B
Enterprise value
12.24B8.58B21.52B37.17B30.56B
P/E ratio
29.3515.9930.2138.27106.2
Price to sales ratio
2.431.453.545.084.32
POCF ratio
68.614.51-240.74145.6736.37
PFCF ratio
-27.976.17-17.75-42.78-63.73
P/B Ratio
5.183.086.368.676.47
PTB ratio
5.183.086.368.676.47
EV to sales
2.841.643.885.494.86
Enterprise value over EBITDA
13.598.8318.0422.8434.21
EV to operating cash flow
80.095.09-263.64157.4940.93
EV to free cash flow
-32.656.97-19.44-46.25-71.73
Earnings yield
0.030.060.030.030.01
Free cash flow yield
-0.040.16-0.06-0.02-0.02
Debt to equity
0.870.40.610.70.81
Debt to assets
0.380.170.280.310.35
Net debt to EBITDA
1.951.011.571.713.81
Current ratio
11.041.031.050.95
Interest coverage
5.545.4418.8813.292.1
Income quality
0.272.75-0.090.192.14
Dividend Yield
00000
Payout ratio
0.10.070.050.030.12
Sales general and administrative to revenue
0.010.010.010.010.02
Research and developement to revenue
00000
Intangibles to total assets
0.010.010.010.010.02
Capex to operating cash flow
-3.45-0.2712.56-4.41-1.57
Capex to revenue
-0.12-0.09-0.18-0.15-0.19
Capex to depreciation
-2.73-1.96-4-3.03-3.48
Stock based compensation to revenue
00000
Graham number
206.44262.44343.63457.04250.54
ROIC
0.120.150.130.130.04
Return on tangible assets
0.080.080.10.10.03
Graham Net
-48.62-54.05-74.88-81.29-149.72
Working capital
-3.27M133.88M81.54M250.89M-273.47M
Tangible asset value
2B2.43B3.04B3.85B4.04B
Net current asset value
-98.06M69.27M-378.38M155.79M-610.07M
Invested capital
0.870.40.610.70.81
Average receivables
1.54B1.82B2.16B2.74B2.4B
Average payables
815.92M1.33B1.64B1.57B1.84B
Average inventory
856.64M1.07B1.14B1.47B2.41B
Days sales outstanding
131.43145.44146.55175.5490.02
Days payables outstanding
81.94216.84131.97177.28161.18
Days of inventory on hand
120.28129.82112.17174.59268.21
Receivables turnover
2.782.512.492.084.05
Payables turnover
4.451.682.772.062.26
Inventory turnover
3.032.813.252.091.36
ROE
0.180.190.210.230.06
Capex per share
-27-23.15-52.37-53.08-59.82

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q3

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
59.7764.7672.8656.525.9
Net income per share
0.43-2.54-4.18-6.85-12.41
Operating cash flow per share
8.970.179.579.348.88
Free cash flow per share
8.970.179.579.348.88
Cash per share
38.221.40.242.250
Book value per share
216.14213.9213.99201.440
Tangible book value per share
0205.890193.130
Share holders equity per share
216.14213.9213.99201.440
Interest debt per share
3177.283.3223.053.11
Market cap
34.33B27.15B26.03B25.96B21.14B
Enterprise value
35.08B30.56B26.04B30.26B21.14B
P/E ratio
1.02K-136.24-79.42-48.33-21.72
Price to sales ratio
29.321.3918.2223.4341.62
POCF ratio
195.158.21K138.69141.71121.44
PFCF ratio
195.158.21K138.69141.71121.44
P/B Ratio
8.16.486.216.570
PTB ratio
8.16.486.216.570
EV to sales
29.9424.0718.2327.3241.62
Enterprise value over EBITDA
220.43383.19537.88-1.24K-121.34
EV to operating cash flow
199.49.24K138.72165.22121.44
EV to free cash flow
199.49.24K138.72165.22121.44
Earnings yield
000-0.01-0.01
Free cash flow yield
0.0100.010.010.01
Debt to equity
00.8101.090
Debt to assets
00.3500.470
Net debt to EBITDA
4.7142.720.1-176.220
Current ratio
00.9500.930
Interest coverage
1.210.03-0.97-1.94-4.29
Income quality
20.95-0.07-2.29-1.36-0.72
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00.01000
Intangibles to total assets
00.0200.020
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
45.64110.6141.86176.170
ROIC
0.010-0.01-0.010
Return on tangible assets
0-0.010-0.020
Graham Net
38.22-149.70.24-166.510
Working capital
749.31M-273.47M4.73M-244.33M0
Tangible asset value
04.04B03.79B0
Net current asset value
749.31M-610.07M4.73M-1.66B0
Invested capital
00.8101.090
Average receivables
1.12B774.6M774.6M509.22M509.22M
Average payables
919M885.92M885.92M241.9M241.9M
Average inventory
1.02B1.47B1.47B1.07B1.07B
Days sales outstanding
0109.81082.730
Days payables outstanding
0184.9057.270
Days of inventory on hand
0307.680253.130
Receivables turnover
00.8201.090
Payables turnover
00.4901.570
Inventory turnover
00.2900.360
ROE
0-0.01-0.02-0.030
Capex per share
00000

ASTEC.NS Frequently Asked Questions

What is Astec LifeSciences Limited stock symbol ?

Astec LifeSciences Limited is a IN stock and trading under the symbol ASTEC.NS

What is Astec LifeSciences Limited stock quote today ?

Astec LifeSciences Limited stock price is $1242.35 today.

Is Astec LifeSciences Limited stock public?

Yes, Astec LifeSciences Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Similar Market Cap